Paper18505083
Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
Lissoni P and 7 others. Anticancer Res, 2008. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors. Papers, record 18505083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18505083
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Gastrointestinal Neoplasms | Major topic |
| Interleukin-2 | Major topic |
| Lung Neoplasms | Major topic |
| Melatonin | Major topic |
| Palliative Care | Major topic |
| Adult | |
| Aged | |
| Disease Progression | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Metastasis |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40304216 | Melatonin in cancer treatment. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40304216 | PubMed |
| 38668052 | The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. | Curr Oncol | 2024 | https://conductscience.org/library/papers/38668052 | PubMed |
| 36986646 | Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986646 | PubMed |
| 36966349 | Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study. | Trials | 2023 | https://conductscience.org/library/papers/36966349 | PubMed |
| 36735141 | Complementary and Integrative Medicine in Pancreatic Cancer. | Curr Oncol Rep | 2023 | https://conductscience.org/library/papers/36735141 | PubMed |
| 35413810 | The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35413810 | PubMed |
| 34698120 | Empowering Melatonin Therapeutics with Drosophila Models. | Diseases | 2021 | https://conductscience.org/library/papers/34698120 | PubMed |
| 33776451 | Role and Therapeutic Potential of Melatonin in Various Type of Cancers. | Onco Targets Ther | 2021 | https://conductscience.org/library/papers/33776451 | PubMed |
| 33238462 | Cyst Reduction by Melatonin in a Novel Drosophila Model of Polycystic Kidney Disease. | Molecules | 2020 | https://conductscience.org/library/papers/33238462 | PubMed |
| 32545820 | Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32545820 | PubMed |
| 31319607 | Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC). | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31319607 | PubMed |
| 30563247 | Melatonin May Increase Anticancer Potential of Pleiotropic Drugs. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30563247 | PubMed |
| 30510430 | Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30510430 | PubMed |
| 30060531 | Mechanisms Underlying Tumor Suppressive Properties of Melatonin. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30060531 | PubMed |
| 28567065 | The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results. | J Res Med Sci | 2017 | https://conductscience.org/library/papers/28567065 | PubMed |
| 28420185 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28420185 | PubMed |
| 27563655 | Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting. | Ann Transl Med | 2016 | https://conductscience.org/library/papers/27563655 | PubMed |
| 27168951 | Immunotherapy for lung cancer: advances and prospects. | Am J Clin Exp Immunol | 2016 | https://conductscience.org/library/papers/27168951 | PubMed |
| 27102150 | Melatonin as a potential anticarcinogen for non-small-cell lung cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/27102150 | PubMed |
| 25622186 | A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2). | Hum Vaccin Immunother | 2015 | https://conductscience.org/library/papers/25622186 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18505083
GET https://conductscience.org/api/papers/v1/18505083/cited_by?page=2